Active surveillance for prostate cancer: an Australian experience - Concepedia

Concepedia

Publication | Open Access

Active surveillance for prostate cancer: an Australian experience

DOI Full Paper Access

35

Citations

9

References

2012

Year

Joseph Ischia, Chris C Y Pang, Yeng Kwang Tay, C Li Wai Suen, Hau Choong Aw, Mark Frydenberg

British Journal of Urology

Abstract

AS is an acceptable mode of initial treatment in Australian men with low-risk prostate cancer.

References

	Year	Citations
Screening and Prostate-Cancer Mortality in a Randomized European Study Fritz H. Schröder, Jonas Hugosson, Monique J. Roobol, New England Journal of Medicine	2009	4K
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer Laurence Klotz, Liying Zhang, Adam Lam, Journal of Clinical Oncology	2009	1.1K
Expectant Management of Prostate Cancer With Curative Intent: An Update of The Johns Hopkins Experience H. Ballentine Carter, Anna Kettermann, Christopher A. Warlick, The Journal of Urology	2007	330
Outcomes of Men with Screen-Detected Prostate Cancer Eligible for Active Surveillance Who Were Managed Expectantly Roderick C.N. van den Bergh, Stijn Roemeling, Monique J. Roobol, European Urology UrologyCancer EpidemiologyHealth PolicyCancer DetectionCancer Screening	2008	288
Prostate Cancer Mortality Reduction by Prostate-Specific Antigen–Based Screening Adjusted for Nonattendance and Contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC) Monique J. Roobol, Melissa Kerkhof, Fritz H. Schröder, European Urology Screening AdjustedUrologyCancer EpidemiologyCancer DetectionCancer Screening	2009	212
Active surveillance; a reasonable management alternative for patients with prostate cancer: the Miami experience Mark S. Soloway, Cynthia T. Soloway, Steve K. Williams, British Journal of Urology	2007	184
Significant upgrading affects a third of men diagnosed with prostate cancer: predictive nomogram and internal validation Felix K.‐H. Chun, Alberto Briganti, Shahrokh F. Shariat, British Journal of Urology	2006	139
Estimating Lead Time and Overdiagnosis Associated with PSA Screening from Prostate Cancer Incidence Trends Donatello Telesca, Ruth Etzioni, Roman Gulati Biometrics Epidemiology Of CancerUnknown Lead TimePreventive MedicineOncologyCancer Detection	2007	125
COMPARISON OF DIGITAL RECTAL EXAMINATION AND BIOPSY RESULTS WITH THE RADICAL PROSTATECTOMY SPECIMEN Can Öbek, Paul Louis, Francisco Civantos, The Journal of Urology	1999	109

Page 1